What the heck! In the most horrific news ever for (some) women, HRA Pharma, the company that manufactures the European version of Plan B called Norlevo has revised its packaging to indicate that the morning after pill isn't always effective for women over 165 pounds, and it DOES NOT WORK AT ALL FOR WOMEN WHO WEIGH MORE THAN 176 POUNDS (80kg).

Mother Jones reports that the packaging will now read:
"Studies suggest that Norlevo is less effective in women weighing [165 pounds] or more and not effective in women weighing [176 pounds] or more" and that Norlevo "is not recommended…if you weigh [165 pounds] or more"
According to Mother Jones, HRA Pharma was originally prompted to look into the effectiveness of their emergency contraception by a 2011 study out of the University of Edinburgh, Scotland that found that "the risk of pregnancy was more than threefold greater for obese women compared with women with normal body mass index, whichever EC (Emergency Contraception) was taken."

They also found that the risk of pregnancy was particularly high if that emergency contraception was made of levonorgestrel, the hormone found in many of the major over-the-counter morning after pills sold in the United States, like Plan B One-Step.

The study recommends that overweight women use IUDs.